0001214659-22-013281.txt : 20221108 0001214659-22-013281.hdr.sgml : 20221108 20221108102328 ACCESSION NUMBER: 0001214659-22-013281 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221104 FILED AS OF DATE: 20221108 DATE AS OF CHANGE: 20221108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRAENDER LORI J CENTRAL INDEX KEY: 0001752955 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38599 FILM NUMBER: 221367631 MAIL ADDRESS: STREET 1: 30 TECHNOLOGY DRIVE CITY: WARREN STATE: NJ ZIP: 07059 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aquestive Therapeutics, Inc. CENTRAL INDEX KEY: 0001398733 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208623253 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 30 TECHNOLOGY DRIVE CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-941-1900 MAIL ADDRESS: STREET 1: 30 TECHNOLOGY DRIVE CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: MonoSol Rx, Inc. DATE OF NAME CHANGE: 20070507 4 1 marketforms-57371.xml PRIMARY DOCUMENT X0306 4 2022-11-04 0001398733 Aquestive Therapeutics, Inc. AQST 0001752955 BRAENDER LORI J C/O AQUESTIVE THERAPEUTICS, INC. 30 TECHNOLOGY DRIVE WARREN NJ 07059 false true false false SVP, General Counsel Non-Qualified Stock Option (right to buy) 0.8750 2022-11-04 4 A false 40000 0 A 2032-11-04 Common Stock 40000 40000 D The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment. /s/ Lori Braender, as Attorney-In-Fact 2022-11-08